Bard Biopsy Systems is classified as operating in the Medical Equipment & Supplies Manufacturing industry, NAICS Code 3391.
Trademark Applications
Trademark applications show the products and services that Bard Biopsy Systems is developing and marketing.
Bard Biopsy Systems doesn't have any recent trademark applications, indicating Bard Biopsy Systems is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
VISILOC Medical devices and apparatus, namely, obturators for identifying the location of lesions and probe placements for breast biopsies, and parts and fittings therefor
08/27/2010
ULTRACOR Medical devices, namely, a syringe which inserts a wire form into a biopsy cavity for easy location of the biopsy cavity periphery
08/07/2009
SENOSONIX medical ultrasound imaging apparatus
07/23/2009
See all trademarks and details in the Full Report.
Market Share of Bard Biopsy Systems's Largest Competitors
A competitive analysis shows these companies are in the same general field as Bard Biopsy Systems, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Bard Biopsy Systems.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Bard Biopsy Systems and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.
My Watch List
